Use of recombinant tissue plasminogen activator in cancer patients with acute stroke
- 18 December 2011
- journal article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 107 (3) , 571-573
Abstract
People with cancer may be at increased risk for stroke, especially of cardioembolic and large vessel origin. Some clinicians are reluctant to use recombinant tissue plasminogen activator (rTPA) in the cancer population due to safety concerns. We conducted a retrospective review of patients who received rTPA for acute stroke at an academic cancer center. We report six patients with cancer treated with rTPA at our institution, four of whom had early neurologic recovery. Only one of our six patients suffered minor bleeding as a complication of rTPA. Acute stroke in patients with cancer may be treated with rTPA, and active cancer should not be considered an absolute contraindication to rTPA use.Keywords
This publication has 13 references indexed in Scilit:
- Risk of Thrombolytic Therapy for Acute Ischemic Stroke in Patients With Current MalignancyJournal of Stroke and Cerebrovascular Diseases, 2011
- Intravenous thrombolysis for acute stroke in patients with cancerJournal of Neurology, Neurosurgery & Psychiatry, 2010
- Coagulopathy and embolic signal in cancer patients with ischemic strokeAnnals of Neurology, 2010
- Nonbacterial Thrombotic Endocarditis (Marantic Endocarditis) in Cancer PatientsCardiovascular & Hematological Disorders-Drug Targets, 2010
- Ischemic Stroke in Cancer Patients With and Without Conventional MechanismsStroke, 2010
- Raloxifene and Risk for Stroke Based on the Framingham Stroke Risk ScoreThe American Journal of Medicine, 2009
- Stroke in cancer patients: a risk factor analysisJournal of Neuro-Oncology, 2009
- Stroke in cancer patients: a risk factor analysisJournal of Neuro-Oncology, 2009
- A User's Guide to the NINDS rt-PA Stroke Trial DatabasePLOS Medicine, 2008
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993